These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 29971780

  • 21. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, Adham M, Tan IB, Haryana SM, Middeldorp JM.
    Int J Cancer; 2006 Aug 01; 119(3):608-14. PubMed ID: 16572427
    [Abstract] [Full Text] [Related]

  • 22. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma.
    Wardana T, Gunawan L, Herawati C, Oktriani R, Anwar S, Astuti I, Aryandono T, Mubarika S.
    Asian Pac J Cancer Prev; 2020 Sep 01; 21(9):2777-2782. PubMed ID: 32986380
    [Abstract] [Full Text] [Related]

  • 23. Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients--evidence of non-exosomal transport.
    Gourzones C, Ferrand FR, Amiel C, Vérillaud B, Barat A, Guérin M, Gattolliat CH, Gelin A, Klibi J, Chaaben AB, Schneider V, Guemira F, Guigay J, Lang P, Jimenez-Pailhes AS, Busson P.
    Virol J; 2013 Apr 16; 10():119. PubMed ID: 23590857
    [Abstract] [Full Text] [Related]

  • 24. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
    Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, Chen J, Rao D, Ye W, Cao S, Hong M.
    Int J Cancer; 2012 Jul 15; 131(2):406-16. PubMed ID: 21866545
    [Abstract] [Full Text] [Related]

  • 25. Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults.
    Yang L, Kartsonaki C, Simon J, Yao P, Guo Y, Lv J, Walters RG, Chen Y, Fry H, Avery D, Yu C, Jin J, Mentzer AJ, Allen N, Butt J, Hill M, Li L, Millwood IY, Waterboer T, Chen Z.
    Int J Epidemiol; 2024 Jun 12; 53(4):. PubMed ID: 39008896
    [Abstract] [Full Text] [Related]

  • 26. Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research.
    Zhang PF, Zheng XH, Li XZ, Tian T, Zhang SD, Hu YZ, Jia WH.
    Cancer Commun (Lond); 2018 Apr 12; 38(1):8. PubMed ID: 29764493
    [Abstract] [Full Text] [Related]

  • 27. Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection.
    Qiu SF, Zhang QZ, Wu ZY, Liu MZ, Ding Q, Sun FM, Wang Y, Yang HX, Zheng L, Chen X, Wu L, Bai J, Liu JF, Chen CB.
    EBioMedicine; 2024 Oct 12; 108():105321. PubMed ID: 39265506
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O, Juwana H, Verkuijlen SA, Adham M, Pegtel MD, Greijer AE, Middeldorp JM.
    Int J Cancer; 2017 Jan 01; 140(1):149-162. PubMed ID: 27600027
    [Abstract] [Full Text] [Related]

  • 29. A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma.
    Zhou X, Cao SM, Cai YL, Zhang X, Zhang S, Feng GF, Chen Y, Feng QS, Chen Y, Chang ET, Liu Z, Adami HO, Liu J, Ye W, Zhang Z, Zeng YX, Xu M.
    Nat Commun; 2021 Aug 31; 12(1):5189. PubMed ID: 34465768
    [Abstract] [Full Text] [Related]

  • 30. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H, Zou X, Wu L, Zhang S, Wang T, Liu P, Zhu W, Zhu J.
    Cancer Med; 2020 Feb 31; 9(3):1230-1241. PubMed ID: 31856390
    [Abstract] [Full Text] [Related]

  • 31. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.
    Ji MF, Sheng W, Cheng WM, Ng MH, Wu BH, Yu X, Wei KR, Li FG, Lian SF, Wang PP, Quan W, Deng L, Li XH, Liu XD, Xie YL, Huang SJ, Ge SX, Huang SL, Liang XJ, He SM, Huang HW, Xia SL, Ng PS, Chen HL, Xie SH, Liu Q, Hong MH, Ma J, Yuan Y, Xia NS, Zhang J, Cao SM.
    Ann Oncol; 2019 Oct 01; 30(10):1630-1637. PubMed ID: 31373615
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
    Zheng XH, Wang RZ, Li XZ, Zhou T, Zhang JB, Zhang PF, Lu LX, Jia WH.
    Cancer Sci; 2020 Feb 01; 111(2):592-600. PubMed ID: 31834989
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X, Zhu D, Zhang H, Zhang S, Zhou X, He X, Zhu J, Zhu W.
    Gene; 2020 Feb 15; 727():144243. PubMed ID: 31743768
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
    Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W.
    Int J Infect Dis; 2014 Aug 15; 25():110-5. PubMed ID: 24878579
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
    Zheng XH, Li XZ, Zhou T, Jiang CT, Tang CL, Deng CM, Liao Y, He YQ, Wang TM, Jia WH.
    Int J Cancer; 2023 Jun 15; 152(12):2629-2638. PubMed ID: 36878711
    [Abstract] [Full Text] [Related]

  • 40. [Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].
    Luo YL, Chen H, Peng SG, Lin JH, Huang PY.
    Zhonghua Yi Xue Za Zhi; 2013 Nov 26; 93(44):3516-9. PubMed ID: 24521892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.